维普中文期刊产品整合服务
25篇 您的检索式:作者名="Sayer RA"
    题名 作者 年代 出处 被引量
1Use of leukocytedepleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant显示文摘Bowden RA Slichter SJ Sayers MH 0,,01:1
2High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer显示文摘 Lancaster JM Pit:man J 2005Gynecol Oncol2005,96,2:1
3A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV)seronegative blood products for the prevention of transfusionassociated CMV infection after marrow transplant显示文摘Bowden RA Slichter SJ Sayers M 0,,09:1
4The management of acute bronchitis in general practice: results from the Australian Morbidity and Treatment Survey, 1990- 1991显示文摘Meza RA Bridges-Webb C Sayer GP Miles DA Traynor V Neary S 1994Aust Faro Physician1994,23,:1
5Cytoreductive surgery for patients with recurrent epithelial ovarian careinoma显示文摘Tebes SJ Sayer RA Palmer JM 2007Gynecol Oncol2007,106,3:1
6High insulin-like growth factor II (IGF-II) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer显示文摘Sayer RA Lancaster JM Pittman J 2005GynecolOnco2005,96,35:1
7High insulin-like growth factor-2 (IGF-2)gene expression is an indepen-dent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer显示文摘Sayer RA Lancaster JM Pittman J 2005Gynecol Oncol2005,96,2:1
8High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels显示文摘Lancaster JM Sayer RA Blanchette C 2006Int J Gynecol Cancer2006,16,4:1
9Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma显示文摘Tebes SJ Sayer RA Palmer JM 2007Gynecol Oncol2007,106,3:1
10Prognostic implicatio ns of ventricular prognostic implications of ventricular fibrillation in acute myocardial infarction:new strategies required mortality re duction显示文摘 Archbold RA Wilknson P 2000Heart2000,84,2:1
11High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer 显示文摘Sayer RA Lancaster JM Pittman J 2005Gyneeol Oneol2005,96,:1
12Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma显示文摘Tebes SJ Sayer RA Palmer JM 2007Gynecol Oncol2007,106,3:1
13High insulin-like growth factor-2(IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer显示文摘Sayer RA Lancaster JM Pittman J 2005Gynecol Oncol2005,96,2:1
14Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation显示文摘Bowden RA Sayers M Flournoy N 0,,:1
15High insulin-like growth factor-2 (IGF-2) gene expression is an independent pre- dictor of poorsurvival for patients with advanced stage serous epithe- lial ovarian cancer显示文摘Sayer RA Lancaster JM Pittman J 2005Gyneeol Oncol2005,96,:1
16Cytoreductive surgery forpatients with recurrent epithelial ovarian carcinoma显示文摘Tebes SJ Sayer RA Palmer JM 2007GynecolOncol2007,106,3:1
17Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma显示文摘Tebes SJ Sayer RA Palmer JM 2007Gynecol Oncol2007,106,3:1
18High insulin like growth factor-2 (IGF-2) gene expression is an independent predictor of poorsurvival for patients with advanced stage serous epithelial ovarian cancer显示文摘Sayer RA Lancaster JM Pittman J 2005Gynecol Oneol2005,96,:1
19High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer显示文摘Sayer RA Lancaster JM Pittman J 2005Gynecol Oncol2005,96,2:1
20High insulin-like growth factor-II(IGF-II) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer显示文摘Sayer RA Lancaster JM Pittman J 2005GynecolOnco2005,96,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费